超过5%股东持股披露「修订」
Apogee Therapeutics(APGE)04-02 05:45
$Apogee Therapeutics(APGE)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001104659-24-041995 Act: 34 Size: 107 KB 网页链接
简介：Apogee Therapeutics, Inc.于2023年6月9日作为一家特拉华州公司成立，与此次发行有关，作为一家控股公司，将全资拥有Apogee Therapeutics，LLC，并间接拥有其子公司。该公司是一家生物技术公司，致力于开发用于治疗特应性皮炎、慢性阻塞性肺病及相关炎症和免疫学适应症的差异化生物制剂，这些适应症的需求尚未得到满足。该公司的抗体项目旨在克服现有疗法的局限性，针对的是成熟的作用机制，并结合先进的抗体工程来优化半衰期和其他特性。
| 今开：40.13 | 昨收：39.95 |
| 最高：40.83 | 最低：38.17 |
| 涨停价： | 跌停价： |
| 总市值：2300244662 |
Apogee Therapeutics(APGE)04-02 05:45
$Apogee Therapeutics(APGE)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001104659-24-041995 Act: 34 Size: 107 KB 网页链接
Apogee Therapeutics(APGE)05-13 19:15
$Apogee Therapeutics(APGE)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001558370-24-007861 Act: 34 Size: 7 MB 网页链接
Apogee Therapeutics(APGE)05-28 19:45
$Apogee Therapeutics(APGE)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001104659-24-065324 Act: 34 Size: 44 KB 网页链接
Apogee Therapeutics(APGE)06-08 04:05
$Apogee Therapeutics(APGE)$ 8-K Current report, item 5.07 Accession Number: 0001104659-24-069619 Act: 34 Size: 214 KB 网页链接
Apogee Therapeutics(APGE)06-08 08:05
$Apogee Therapeutics(APGE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-069790 Size: 12 KB 网页链接
Apogee Therapeutics(APGE)04-25 04:25
$Apogee Therapeutics(APGE)$ DEF 14A Other definitive proxy statements Accession Number: 0001104659-24-051224 Act: 34 Size: 1 MB 网页链接
Apogee Therapeutics(APGE)04-25 04:25
$Apogee Therapeutics(APGE)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001104659-24-051228 Act: 34 Size: 720 KB 网页链接
Apogee Therapeutics(APGE)05-16 04:45
$Apogee Therapeutics(APGE)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001104659-24-061998 Act: 34 Size: 230 KB 网页链接
Apogee Therapeutics(APGE)06-08 08:05
$Apogee Therapeutics(APGE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-069793 Size: 13 KB 网页链接
Apogee Therapeutics(APGE)06-08 08:15
$Apogee Therapeutics(APGE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-069803 Size: 12 KB 网页链接
BeeBee资讯03-06 11:55
🥇 涨幅榜：
1️⃣ Apogee Therapeutics, Inc. (APGE) - 股价大幅上涨42.07%，达到59.30美元！🌟 公司APG777的Phase 1健康志愿者试验中期结果积极，加上生物制药发展的战略进展，吸引了投资者的极大兴趣。
2️⃣ New York Community Bancorp, Inc. (NYCB) - 股价...查看全文
chuminhua03-06 10:50
3/6，Apogee Pharmaceuticals $Apogee Therapeutics(APGE)$ 股价周二飙升 42%，此前该制药商表示，其 IL-13 抑制剂的临时 I 期数据表明，通过每三至六个月注射一次的维持给药方案，该抑制剂可以有效治疗特应性皮炎。 该公司计划今年下半年针对中重度疾病患者启动一项2期试验。
候选药物 APG777...查看全文
产业链观察03-05 21:48
#药闻简讯# $Apogee Therapeutics(APGE)$ 报告APG777 1期健康志愿者临床试验的积极中期结果超出了目标，半衰期约为75天，这支持了更高的暴露潜力，从而有可能改善诱导的临床反应，以及每3个月或6个月维持给药的潜力
APG777 1期中期数据支持2024年上半年中度至重度特应性皮炎患者随机、安慰剂对...查看全文
牛唐2023-07-24 18:29
Biotech IPO热度回升，一周之内出现三家大额募资：$Apogee Therapeutics(APGE)$ 募资了3亿美元，$Sagimet Biosciences(SGMT)$ 募资8500万美元，$Turnstone Biologics(TSBX)$ 募资8000万美元。查看全文
$Apogee Therapeutics(APGE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-069797 Size: 5 KB 网页链接
$Apogee Therapeutics(APGE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-069798 Size: 5 KB 网页链接
$Apogee Therapeutics(APGE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-069803 Size: 12 KB 网页链接
$Apogee Therapeutics(APGE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-069790 Size: 12 KB 网页链接
$Apogee Therapeutics(APGE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-069795 Size: 12 KB 网页链接
$Apogee Therapeutics(APGE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-069792 Size: 13 KB 网页链接
$Apogee Therapeutics(APGE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-069793 Size: 13 KB 网页链接
$Apogee Therapeutics(APGE)$ 8-K Current report, item 5.07 Accession Number: 0001104659-24-069619 Act: 34 Size: 214 KB 网页链接
$Apogee Therapeutics(APGE)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001104659-24-066784 Size: 9 KB 网页链接
$Apogee Therapeutics(APGE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-066788 Size: 5 KB 网页链接